
|Articles|February 1, 2004
Only constant is change in DT's 25 years
We've seen sweeping changes in treatments, how medical care is delivered, and how it is paid in 25 years of publishing Dermatology Times.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
2
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
3
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
4
Case Report Highlights Rural Care Gaps in Recurrent Merkel Cell Carcinoma
5











